US Edition
GLP-1 drugs: The path to the future of health?
Summary by Portfolio Adviser
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
GLP-1 drugs: The path to the future of health?
By Simone Poma (pictured left) and Leonildo Delgado (pictured right), portfolio managers of the JSS Sustainable Equity – Future Health fund GLP-1 drugs have been compared to the discovery of penicillin, which changed the course of medicine by treating several life-threatening illnesses. Originally developed as diabetes treatments, they have garnered much attention because of their ability to support weight loss by increasing satiety, reducing fo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
